Compounds as sumo activating enzyme inhibitors
AssigneeWigen Biomedicine Technology (Shanghai) Co., Ltd.
InventorsYuli XIE, Yingming WU, Lihui QIAN
Life of this patent
Estimating the term…
Loading patent…
AssigneeWigen Biomedicine Technology (Shanghai) Co., Ltd.
InventorsYuli XIE, Yingming WU, Lihui QIAN
Estimating the term…
Disclosed in the present disclosure are compounds as SUMO activating enzyme inhibitors. Specifically, the present disclosure relates to a compound of general formula (1), a method for preparing same, and use of the compound of general formula (1) and isomers, crystalline forms, pharmaceutically acceptable salts, hydrates or solvates thereof as SAE inhibitors. The compound and the isomer thereof, the crystalline form thereof, the pharmaceutically acceptable salt thereof, the hydrate thereof, or the solvate thereof of the present disclosure can be used in preparing a medicament for treating or preventing a disease related to SAE protein.
A compound of general formula (1) or an isomer thereof, a crystalline form thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof:
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.